Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin.
Scope of the Report:
This report studies the Hydroxyzine Imine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hydroxyzine Imine market by product type and applications/end industries.
It is also used along with other medications given during and after general anesthesia to produce synergistic effects. Key factors driving the growth of this market are the increase in population with allergic reactions coupled with rise in geriatric population.
The global Hydroxyzine Imine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hydroxyzine Imine.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries
Shanghai Ruizheng Chemical Technology Co., Ltd
Lupin Pharmaceuticals, Inc.
N&R Industries
OAK PHARMS INC.
Changzhou ComWin Fine Chemicals Co., Ltd
Novartis International AG
Impax Laboratories, Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablet
Capsule
Syrup
Injection
Market Segment by Applications, can be divided into
Urticaria
Histamine-Mediated Pruritus and Atopic
Contact Dermatoses
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hydroxyzine Imine Market Overview
1.1 Product Overview and Scope of Hydroxyzine Imine
1.2 Classification of Hydroxyzine Imine by Types
1.2.1 Global Hydroxyzine Imine Revenue Comparison by Types (2017-2023)
1.2.2 Global Hydroxyzine Imine Revenue Market Share by Types in 2017
1.2.3 Tablet
1.2.4 Capsule
1.2.5 Syrup
1.2.6 Injection
1.3 Global Hydroxyzine Imine Market by Application
1.3.1 Global Hydroxyzine Imine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Urticaria
1.3.3 Histamine-Mediated Pruritus and Atopic
1.3.4 Contact Dermatoses
1.4 Global Hydroxyzine Imine Market by Regions
1.4.1 Global Hydroxyzine Imine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hydroxyzine Imine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hydroxyzine Imine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hydroxyzine Imine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hydroxyzine Imine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hydroxyzine Imine Status and Prospect (2013-2023)
1.5 Global Market Size of Hydroxyzine Imine (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Business Overview
2.1.2 Hydroxyzine Imine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inc. Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline plc
2.2.1 Business Overview
2.2.2 Hydroxyzine Imine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline plc Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Hydroxyzine Imine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.4 Shanghai Ruizheng Chemical Technology Co., Ltd
2.4.1 Business Overview
2.4.2 Hydroxyzine Imine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shanghai Ruizheng Chemical Technology Co., Ltd Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lupin Pharmaceuticals, Inc.
2.5.1 Business Overview
2.5.2 Hydroxyzine Imine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lupin Pharmaceuticals, Inc. Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.6 N&R Industries
2.6.1 Business Overview
2.6.2 Hydroxyzine Imine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 N&R Industries Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.7 OAK PHARMS INC.
2.7.1 Business Overview
2.7.2 Hydroxyzine Imine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 OAK PHARMS INC. Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.8 Changzhou ComWin Fine Chemicals Co., Ltd
2.8.1 Business Overview
2.8.2 Hydroxyzine Imine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Changzhou ComWin Fine Chemicals Co., Ltd Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis International AG
2.9.1 Business Overview
2.9.2 Hydroxyzine Imine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis International AG Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
2.10 Impax Laboratories, Inc
2.10.1 Business Overview
2.10.2 Hydroxyzine Imine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Impax Laboratories, Inc Hydroxyzine Imine Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hydroxyzine Imine Market Competition, by Players
3.1 Global Hydroxyzine Imine Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hydroxyzine Imine Players Market Share
3.2.2 Top 10 Hydroxyzine Imine Players Market Share
3.3 Market Competition Trend
4 Global Hydroxyzine Imine Market Size by Regions
4.1 Global Hydroxyzine Imine Revenue and Market Share by Regions
4.2 North America Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
4.3 Europe Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
4.5 South America Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
5 North America Hydroxyzine Imine Revenue by Countries
5.1 North America Hydroxyzine Imine Revenue by Countries (2013-2018)
5.2 USA Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
5.3 Canada Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
5.4 Mexico Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
6 Europe Hydroxyzine Imine Revenue by Countries
6.1 Europe Hydroxyzine Imine Revenue by Countries (2013-2018)
6.2 Germany Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
6.3 UK Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
6.4 France Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
6.5 Russia Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
6.6 Italy Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hydroxyzine Imine Revenue by Countries
7.1 Asia-Pacific Hydroxyzine Imine Revenue by Countries (2013-2018)
7.2 China Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
7.3 Japan Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
7.4 Korea Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
7.5 India Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
8 South America Hydroxyzine Imine Revenue by Countries
8.1 South America Hydroxyzine Imine Revenue by Countries (2013-2018)
8.2 Brazil Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
8.3 Argentina Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
8.4 Colombia Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hydroxyzine Imine by Countries
9.1 Middle East and Africa Hydroxyzine Imine Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
9.3 UAE Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
9.4 Egypt Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
9.6 South Africa Hydroxyzine Imine Revenue and Growth Rate (2013-2018)
10 Global Hydroxyzine Imine Market Segment by Type
10.1 Global Hydroxyzine Imine Revenue and Market Share by Type (2013-2018)
10.2 Global Hydroxyzine Imine Market Forecast by Type (2018-2023)
10.3 Tablet Revenue Growth Rate (2013-2023)
10.4 Capsule Revenue Growth Rate (2013-2023)
10.5 Syrup Revenue Growth Rate (2013-2023)
10.6 Injection Revenue Growth Rate (2013-2023)
11 Global Hydroxyzine Imine Market Segment by Application
11.1 Global Hydroxyzine Imine Revenue Market Share by Application (2013-2018)
11.2 Hydroxyzine Imine Market Forecast by Application (2018-2023)
11.3 Urticaria Revenue Growth (2013-2018)
11.4 Histamine-Mediated Pruritus and Atopic Revenue Growth (2013-2018)
11.5 Contact Dermatoses Revenue Growth (2013-2018)
12 Global Hydroxyzine Imine Market Size Forecast (2018-2023)
12.1 Global Hydroxyzine Imine Market Size Forecast (2018-2023)
12.2 Global Hydroxyzine Imine Market Forecast by Regions (2018-2023)
12.3 North America Hydroxyzine Imine Revenue Market Forecast (2018-2023)
12.4 Europe Hydroxyzine Imine Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hydroxyzine Imine Revenue Market Forecast (2018-2023)
12.6 South America Hydroxyzine Imine Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hydroxyzine Imine Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hydroxyzine Imine Picture
Table Product Specifications of Hydroxyzine Imine
Table Global Hydroxyzine Imine and Revenue (Million USD) Market Split by Product Type